ANALYSIS OF EXPENDITURE IN MULTIPLE SCLEROSIS DISEASE MODIFYING THERAPIES EVOLUTION BETWEEN 2004-2013 IN SPAIN
Author(s)
Villoro R1, Hidalgo A2
1Instituto Max Weber, Madrid, Spain, 2University of Castilla La Mancha, Toledo, Spain
Presentation Documents
OBJECTIVES To analyze factors of recent evolution of Multiple Sclerosis (MS) Disease Modifying Therapies (DMT) budgets in Spain between 2004 and 2013. METHODS
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PND36
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Neurological Disorders